From February 9, 2021 to February 10, 2021, the company has repurchased 6,875,000 shares, representing 22.06% for ¥9,391.25 million. With this, the company has completed the repurchase of 6,875,000 shares, representing 22.06% for ¥9,391.25 million under the buyback announced on February 9, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,457 JPY | -2.02% | -1.89% | -16.22% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.22% | 23Cr | |
+45.82% | 77TCr | |
+40.95% | 63TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.45% | 25TCr | |
+11.88% | 22TCr | |
-0.78% | 22TCr | |
+5.90% | 16TCr |
- Stock Market
- Equities
- 4554 Stock
- News Fuji Pharma Co., Ltd.
- Tranche Update on Fuji Pharma Co., Ltd.'s Equity Buyback Plan announced on February 9, 2021.